D-RiboseCAS# 50-69-1 |
- D-Arabinose
Catalog No.:BCN3791
CAS No.:10323-20-3
- DL-Arabinose
Catalog No.:BCN8541
CAS No.:147-81-9
- D-(+)-Xylose
Catalog No.:BCN1010
CAS No.:58-86-6
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 50-69-1 | SDF | Download SDF |
| PubChem ID | 5311110 | Appearance | Powder |
| Formula | C5H10O5 | M.Wt | 150.13 |
| Type of Compound | Carbohydrates | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (2R,3R,4R)-2,3,4,5-tetrahydroxypentanal | ||
| SMILES | C(C(C(C(C=O)O)O)O)O | ||
| Standard InChIKey | PYMYPHUHKUWMLA-LMVFSUKVSA-N | ||
| Standard InChI | InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h1,3-5,7-10H,2H2/t3-,4+,5-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
D-Ribose Dilution Calculator
D-Ribose Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 6.6609 mL | 33.3045 mL | 66.6089 mL | 133.2179 mL | 166.5223 mL |
| 5 mM | 1.3322 mL | 6.6609 mL | 13.3218 mL | 26.6436 mL | 33.3045 mL |
| 10 mM | 0.6661 mL | 3.3304 mL | 6.6609 mL | 13.3218 mL | 16.6522 mL |
| 50 mM | 0.1332 mL | 0.6661 mL | 1.3322 mL | 2.6644 mL | 3.3304 mL |
| 100 mM | 0.0666 mL | 0.333 mL | 0.6661 mL | 1.3322 mL | 1.6652 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- α-L-Rhamnopyranose
Catalog No.:BCN9062
CAS No.:6014-42-2
- (±)-Naringenin
Catalog No.:BCN9061
CAS No.:67604-48-2
- Glucodigifucoside
Catalog No.:BCN9060
CAS No.:2446-63-1
- Trimethyl phosphate
Catalog No.:BCN9059
CAS No.:512-56-1
- N-Phenethylbenzamide
Catalog No.:BCN9058
CAS No.:3278-14-6
- Warfarin sodium
Catalog No.:BCN9057
CAS No.:129-06-6
- Flavokawain A
Catalog No.:BCN9056
CAS No.:37951-13-6
- 5'-Guanylic acid
Catalog No.:BCN9055
CAS No.:85-32-5
- Xanthosine
Catalog No.:BCN9054
CAS No.:146-80-5
- 5'-Cytidylic acid
Catalog No.:BCN9053
CAS No.:63-37-6
- DL-Tartaric acid
Catalog No.:BCN9052
CAS No.:133-37-9
- Mirificin-4'-O-glucoside
Catalog No.:BCN9051
CAS No.:168035-01-6
- Alizarin 1-methyl ether
Catalog No.:BCN9064
CAS No.: 6170-06-5
- Eugenol acetate
Catalog No.:BCN9065
CAS No.:93-28-7
- Citral
Catalog No.:BCN9066
CAS No.:5392-40-5
- 10-hydroxydec-2-enoic acid
Catalog No.:BCN9067
CAS No.:14113-05-4
- Citronellal
Catalog No.:BCN9068
CAS No.:106-23-0
- Benzyl alcohol
Catalog No.:BCN9069
CAS No.:100-51-6
- (-)-Menthone
Catalog No.:BCN9070
CAS No.:14073-97-3
- (+)-Fenchone
Catalog No.:BCN9071
CAS No.:4695-62-9
- Alphalipoic acid
Catalog No.:BCN9072
CAS No.:1077-28-7
- Ferulic Acid Methyl Ester
Catalog No.:BCN9073
CAS No.:2309-07-1
- 3-(β-D-Glucopyranosyloxy)-1,6-dihydroxy-2-methyl-9,10-anthracenedione
Catalog No.:BCN9074
CAS No.:125906-49-2
- (-)-Fenchone
Catalog No.:BCN9075
CAS No.:7787-20-4
Water Treatment Effect, Microbial Community Structure, and Metabolic Characteristics in a Field-Scale Aquaculture Wastewater Treatment System.[Pubmed:32655501]
Front Microbiol. 2020 Jun 5;11:930.
Avoiding and mitigating the introduction of harmful effluent into the environment must be a key part of intensive industrial aquaculture development in order to minimize pollution impacts. We constructed a novel field-scale aquaculture wastewater treatment system (FAWTS) involving three-stage purification to efficiently remove nutrients from effluent wastewater. However, the mechanisms of nutrient attenuation in the FAWTS are still unclear. Since microbiota play an important role in the treatment of aquatic pollutants, we hypothesized that the different stages of FAWTS may have enriched various nutrient-metabolizing bacteria, with these promoting nutrient attenuation. We therefore tested microbial metabolic activity, microbial composition, and their metabolic potential using Biolog-GN2 microplate culture and high-throughput sequencing of prokaryotic 16S rRNA gene amplicons. Our results showed that the FAWTS displayed high removal efficiencies for chemical oxygen demand (COD, 74.4-91.2%), total nitrogen (TN, 66.9-86.8%), and total phosphorus (TP, 76.2-95.9%). Simultaneously, microbial metabolic activity for various carbon sources was significantly enhanced in FAWTS biofilms. Denitrifying and phosphorus-removing bacteria such as Rhodobacter were enriched in these biofilms, and genes participating in denitrification and the pathway from methylphosphonate to alpha-D-Ribose-1,5-bisphosphate were increased in the biofilm communities. These results imply that the transformed multistep purification system effectively removed N, P, and COD from aquaculture wastewater by enhancing the bacterial communities involved in these processes. This suggests that contamination-free aquaculture is a feasible goal, and that microbial communities are central to pollutant removal.
